NEUROD1 DNA methylation has been observed in diffuse large B-cell lymphoma [73] and breast cancer where it was associated with a ten-fold more likely response to neoadjuvant therapy in estrogen receptor-negative cancers [74]. Here, NEUROD1 is linked to breast cancer.